» Articles » PMID: 1450181

LDL Subclass Phenotypes and Triglyceride Metabolism in Non-insulin-dependent Diabetes

Overview
Date 1992 Dec 1
PMID 1450181
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma low density lipoprotein (LDL) comprises multiple discrete subclasses differing in size, density, and chemical composition. A common, heritable phenotype characterized by the predominance of small, dense LDL particles (LDL subclass phenotype B) is associated with relatively increased concentrations of plasma triglycerides, reduced levels of high density lipoprotein, and increased risk of coronary artery disease in comparison with subjects with larger LDL (LDL subclass phenotype A). Population studies have indicated that approximately 20-30% of adult men have phenotype B, and another 15-20% have LDL of intermediate size. The lipid changes in phenotype B are similar to those that have been observed in patients with non-insulin-dependent diabetes mellitus (NIDDM). In the present study, we have assessed LDL subclass phenotypes in normolipidemic men with NIDDM and in age-matched control subjects who had similar lipid levels. There was a greater than twofold increase in the percentage of individuals with the LDL B phenotype in the NIDDM subjects. The LDL B phenotype was associated with higher plasma triglyceride levels and a trend toward lower high density lipoprotein cholesterol levels compared with the LDL A phenotype in the NIDDM subjects, as has been previously observed in control groups. Indices of diabetic control, such as fasting and hemoglobin A1 levels, were similar regardless of LDL phenotype pattern, suggesting that glycemic control was not likely to account for the increase in the LDL B phenotype. In both control and NIDDM subjects, the clearance of triglyceride-rich lipoproteins was slowed in the subjects with the LDL phenotype B compared with those with the A phenotype.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

A Comparison of Rosuvastatin Monotherapy and Rosuvastatin Plus Ezetimibe Combination Therapy in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.

Dadzie S, Tabowei G, Kaur M, Ahmed S, Thakur A, Khreis K Cureus. 2024; 16(6):e61526.

PMID: 38957250 PMC: 11218846. DOI: 10.7759/cureus.61526.


Role of Small Dense Low-density Lipoprotein Cholesterol in Cardiovascular Events in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Receiving Statin Treatment.

Yamaji T, Harada T, Kajikawa M, Maruhashi T, Kishimoto S, Yusoff F J Atheroscler Thromb. 2023; 31(4):478-500.

PMID: 37926523 PMC: 10999715. DOI: 10.5551/jat.64416.


The influence of somatic maturity on the relationship between the triglyceride/high-density lipoprotein ratio and vascular health in children and adolescents with dyslipidemia.

Talluri R, Sherman A, Goth N, Simpson K, Kuzava L, Raghuveer G Am J Hum Biol. 2022; 35(2):e23815.

PMID: 36196910 PMC: 9931626. DOI: 10.1002/ajhb.23815.


Antilipidemic and Hepatoprotective Effects of Ethanol Extract of in Streptozotocin Diabetic Rats.

Murillo-Villicana M, Noriega-Cisneros R, Pena-Montes D, Huerta-Cervantes M, Aguilera-Mendez A, Cortes-Rojo C Nutrients. 2022; 14(9).

PMID: 35565913 PMC: 9099835. DOI: 10.3390/nu14091946.


Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic Emirates.

Rimbert A, Daggag H, Lansberg P, Buckley A, Viel M, Kanninga R Front Genet. 2022; 12:809256.

PMID: 35047021 PMC: 8762259. DOI: 10.3389/fgene.2021.809256.